Knight Therapeutics Inc (KHTRF) (Q3 2026) Earnings Call Highlights: Record Revenue, Raised ...
Knight Therapeutics Inc (KHTRF) posted record first nine months revenue of $430 million, lifted its 2026 guidance and boosted peak pipeline revenue expectations to over $300 million. Related Stocks: KHTRF ,